Balance Sheet
Accounts PayablesAssetsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueGoodwill & IntangiblesIntangiblesLiabilities and Shareholders EquityNon-Current AssetsNon-Current Deffered RevenueOther Non-Current AssetsPayablesPrepaid AssetsRetained EarningsShareholder's EquityShares OutstandingTotal Current LiabilitiesTotal LiabilitiesTotal Non-Current Liabilities
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Silo Pharma (SILO) Total Current Liabilities (2017 - 2025)

Historic Total Current Liabilities for Silo Pharma (SILO) over the last 10 years, with Q3 2025 value amounting to $708339.0.

  • Silo Pharma's Total Current Liabilities fell 3220.55% to $708339.0 in Q3 2025 from the same period last year, while for Sep 2025 it was $708339.0, marking a year-over-year decrease of 3220.55%. This contributed to the annual value of $1.7 million for FY2024, which is 11351.45% up from last year.
  • Latest data reveals that Silo Pharma reported Total Current Liabilities of $708339.0 as of Q3 2025, which was down 3220.55% from $1.0 million recorded in Q2 2025.
  • Silo Pharma's 5-year Total Current Liabilities high stood at $1.7 million for Q4 2024, and its period low was $264135.0 during Q2 2021.
  • Moreover, its 5-year median value for Total Current Liabilities was $708339.0 (2025), whereas its average is $727500.5.
  • Its Total Current Liabilities has fluctuated over the past 5 years, first soared by 31666.83% in 2023, then crashed by 3220.55% in 2025.
  • Quarter analysis of 5 years shows Silo Pharma's Total Current Liabilities stood at $490039.0 in 2021, then decreased by 10.96% to $436318.0 in 2022, then surged by 77.76% to $775590.0 in 2023, then soared by 113.51% to $1.7 million in 2024, then crashed by 57.23% to $708339.0 in 2025.
  • Its last three reported values are $708339.0 in Q3 2025, $1.0 million for Q2 2025, and $1.2 million during Q1 2025.